Rwanda Initiates Marburg Vaccine Trials Amid Rising Cases
Rwanda is set to commence clinical trials for vaccines and treatments against the Marburg viral disease, according to Health Minister Yvan Butera. The country confirmed the disease in September, resulting in 11 deaths and 36 reported cases so far.
- Country:
- Rwanda
Rwanda is on the verge of beginning clinical trials for vaccines and therapeutics aimed at combatting the Marburg viral disease, Health Minister Yvan Butera announced on Thursday.
The viral disease, officially identified in Rwanda in late September, has so far resulted in 11 fatalities, with a total of 36 cases reported, according to data from the health ministry.
The initiation of these trials marks a critical step in the country's ongoing efforts to control the outbreak and prevent further casualties.
ALSO READ
-
Beyond the Classroom: Why Social and Emotional Learning Needs Stronger Policy Roots
-
EU–ILO Network Connects Youth Employment Evidence With Policy Action in Three Countries
-
Rwanda’s Next Growth Chapter Depends on Unlocking More Capital, Skills and Investment
-
Rwanda Moves Towards $35.7 Million IMF Release as Strong Growth Meets Inflation Pressure
-
AI in Courts Could Open Doors to Justice or Leave Vulnerable People Further Behind
Google News